Diabetes in midlife and cognitive change over 20 years: A cohort study

Annals of Internal Medicine

Volumn 161, Issue 11, 2014, Pages 785-793

  Rawlings, Andreea M ^a   Sharrett, A Richey ^a   Schneider, Andrea L C ^a   Coresh, Josef ^a   Albert, Marilyn ^b   Couper, David ^c   Griswold, Michael ^d   Gottesman, Rebecca F ^b   Wagenknecht, Lynne E ^e   Windham, B Gwen ^f   Selvin, Elizabeth ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLACK PERSON; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DETERIORATION; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; SELF REPORT; WECHSLER INTELLIGENCE SCALE; WORD RECOGNITION; AFRICAN AMERICAN; BLOOD; CAUCASIAN; COMPLICATION; ETHNOLOGY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PROPENSITY SCORE; RISK FACTOR;

AFRICAN AMERICANS; AGED; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPENSITY SCORE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84919491272     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-0737     Document Type: Article

References (39)

1. Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med. 2014;160:517-25. [PMID: 24733192] doi:10.7326/M13-2411
2. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829-41. [PMID: 21366474] doi:10.1056/NEJMoa1008862
3. Sarwar N, Aspelund T, Eiriksdottir G, Gobin R, Seshasai SR, Forouhi NG, et al. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med. 2010;7:e1000278. [PMID: 20520805] doi:10.1371/journal.pmed.1000278
4. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376: 124-36. [PMID: 20580421] doi:10.1016/S0140-6736(09)62124-3
5. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64-74. [PMID: 16361024]
6. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies. Diabetologia. 2005;48:2460-9. [PMID: 16283246]
7. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42:484-91. [PMID: 22372522] doi:10.1111/j.1445-5994.2012.02758.x
8. Power MC, Tchetgen EJ, Sparrow D, Schwartz J, Weisskopf MG. Blood pressure and cognition: factors that may account for their inconsistent association. Epidemiology. 2013;24:886-93. [PMID: 24030502] doi:10.1097/EDE.0b013e3182a7121c
9. Alonso A, Mosley TH Jr, Gottesman RF, Catellier D, Sharrett AR, Coresh J. Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry. 2009;80:1194-201. [PMID: 19692426] doi:10.1136/jnnp.2009.176818
10. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care. 2014;37 Suppl 1:S14-80. [PMID: 24357209] doi:10.2337/dc14-S014
11. Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69:1170-5. [PMID: 22710333] doi:10.1001/archneurol.2012.1117
12. Sanz CM, Ruidavets JB, Bongard V, Marquié JC, Hanaire H, Ferrières J, et al. Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study. Diabetes Care. 2013;36:1512-21. [PMID: 23275371] doi:10.2337/dc12-1017
13. Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, et al; ACCORD MIND investigators. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969-77. [PMID: 21958949] doi:10.1016/S1474-4422(11)70188-0
14. Herzog RI, Sherwin RS. Diabetes. Can tight glycemic control in diabetes benefit cognition? Nat Rev Neurol. 2011;8:124-6. [PMID: 22290574] doi:10.1038/nrneurol.2012.10
15. Tuligenga RH, Dugravot A, Tabák AG, Elbaz A, Brunner EJ, Kivimäki M, et al. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2014;2:228-35. [PMID: 24622753] doi:10.1016/S2213-8587(13)70192-X
16. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC Investigators. Am J Epidemiol. 1989;129:687-702. [PMID: 2646917]
17. Knopman DS, Ryberg S. A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch Neurol. 1989;46:141-5. [PMID: 2916953]
18. Wechsler D. Manual for the Wechsler Adult Intelligence Scale, Revised. New York: Psychological Corp; 1981.
19. Benton AL, Hamsher K. Multilingual Aphasia Examination (2nd ed). Iowa City, IA: AJA Associates; 1989.
20. Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K, et al. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC Neurocognitive Study. Am J Epidemiol. 2014;179:956-66. [PMID: 24627572] doi:10.1093/aje/kwu020
21. Schneider AL, Sharrett AR, Gottesman RF, Coresh J, Coker L, Wruck L, et al. Normative data for 8 neuropsychological tests in older blacks and whites from the Atherosclerosis Risk in Communities (ARIC) study. Alzheimer Dis Assoc Disord. 2014. [PMID: 24759546]
22. Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care. 1997;20:1388-95. [PMID: 9283785]
23. Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Overview and findings from the Rush Memory and Aging Project. Curr Alzheimer Res. 2012;9:646-63. [PMID: 22471867]
24. Wilson RS, Segawa E, Boyle PA, Bennett DA. Influence of late-life cognitive activity on cognitive health. Neurology. 2012;78:1123-9. [PMID: 22491864] doi:10.1212/WNL.0b013e31824f8c03
25. Selvin E, Ning Y, Steffes MW, Bash LD, Klein R, Wong TY, et al. Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes. 2011;60:298-305. [PMID: 20978092] doi:10.2337/db10-1198
26. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168:656-64. [PMID: 18682488] doi: 10.1093/aje/kwn164
27. Weuve J, Tchetgen Tchetgen EJ, Glymour MM, Beck TL, Aggarwal NT, Wilson RS, et al. Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology. 2012;23:119-28. [PMID: 21989136] doi:10.1097/EDE.0b013e318230e861
28. Christman AL, Matsushita K, Gottesman RF, Mosley T, Alonso A, Coresh J, et al. Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia. 2011;54:1645-52. [PMID: 21360189] doi:10.1007/s00125-011-2095-7
29. Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement. 2009;5:207-14. [PMID: 19362884] doi:10.1016/j.jalz.2009.01.027
30. Jokinen H, Kalska H, Mäntylä R, Pohjasvaara T, Ylikoski R, Hietanen M, et al. Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry. 2006;77:28-33. [PMID: 16361588]
31. O'Brien JT, Wiseman R, Burton EJ, Barber B, Wesnes K, Saxby B, et al. Cognitive associations of subcortical white matter lesions in older people. Ann N Y Acad Sci. 2002;977:436-44. [PMID: 12480784]
32. Selnes OA, Vinters HV. Vascular cognitive impairment. Nat Clin Pract Neurol. 2006;2:538-47. [PMID: 16990827]
33. Spauwen PJ, Köhler S, Verhey FR, Stehouwer CD, van Boxtel MP. Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study. Diabetes Care. 2013;36:1554-61. [PMID: 23275366] doi:10.2337/dc12-0746
34. Kaffashian S, Dugravot A, Elbaz A, Shipley MJ, Sabia S, Kivimäki M, et al. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology. 2013;80:1300-6. [PMID: 23547265] doi:10.1212/WNL.0b013e31828ab370
35. Bangen KJ, Beiser A, Delano-Wood L, Nation DA, Lamar M, Libon DJ, et al. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline. J Stroke Cerebrovasc Dis. 2013;22:1361-9. [PMID: 23601373] doi:10.1016/j.jstrokecerebrovasdis.2013.03.013
36. Gerstein HC. Do lifestyle changes reduce serious outcomes in diabetes? [Editorial]. N Engl J Med. 2013;369:189-90. [PMID: 23796132] doi:10.1056/NEJMe1306987
37. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337-42. [PMID: 9736873]
38. Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996;52:249-64. [PMID: 8934595]
39. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11:561-70. [PMID: 10955409]